NCT01594034

Brief Summary

Our objective is to determine whether or not the presence of hemoperitoneum in trauma patients is associated with increased Carbon Monoxide (CO) formation, and to determine if elevated Carbon Monoxide levels are associated with cardiovascular depression, impaired platelet aggregation, and/or multiple organ failure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

May 4, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 8, 2012

Completed
Last Updated

May 14, 2012

Status Verified

May 1, 2012

Enrollment Period

1.5 years

First QC Date

May 4, 2012

Last Update Submit

May 11, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • •Establish a method for reliably measuring CO excretion in patients.

    96 hours

Study Arms (1)

no treatment

Procedure: expired air

Interventions

expired airPROCEDURE

collection of expired air from ventilator

no treatment

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients in the ICU on a ventilator

You may qualify if:

  • Hospitalized males 18 years of age or older,
  • Diagnosis of isolated blunt OR blunt and penetrating trauma,
  • Admitted or expecting to be admitted to the Intensive Care Unit,
  • On mechanical ventilation, and
  • Written informed consent obtained

You may not qualify if:

  • Female gender, (Females will be excluded from this study as the menstrual cycle and other estrogen variations are known to be associated with cyclic changes in CO production adding a potential confounder to the interpretations of our findings.)
  • Diagnosis of isolated penetrating trauma,
  • Acute hemothorax or pneumothorax,
  • Treatment with antiaggregants (ASA, clopidogrel, aggrenox or ticlopidine),
  • Enrollment in another research study,
  • Prisoners,
  • Inability to perform CO measurement within 96 hours after hospital admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

San Antonio, Texas, 78229, United States

Location

MeSH Terms

Conditions

Hemoperitoneum

Condition Hierarchy (Ancestors)

Peritoneal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Robert Johnson, PhD

    University of Texas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2012

First Posted

May 8, 2012

Study Start

November 1, 2009

Primary Completion

May 1, 2011

Study Completion

May 1, 2011

Last Updated

May 14, 2012

Record last verified: 2012-05

Locations